Search Results 1-10 of 18050 for multiple%20sclerosis
Secondary-progressive MS. At least 20% to 40% of people with relapsing-remitting multiple sclerosis can eventually develop a steady progression of symptoms.
Well, the first drug approved by the FDA for treatment of multiple sclerosis was in 1993. Since then, over 20 drugs have become available for treatment of MS.
Mayo Clinic also developed plasma exchange and has been successfully using this treatment for more than 20 years. Research. Mayo Clinic experts continually ...
According to the Multiple Sclerosis Association of America, more than 400,000 Americans are living with MS. About 20 percent of them have a parent, child or ...
This article discusses managing multiple sclerosis, an autoimmune disease in which a person's immune system attacks the body.
Through research in the Center for Multiple Sclerosis and Autoimmune Neurology, Mayo Clinic is leading scientific advances in multiple sclerosis treatment.
Diagnosed with multiple sclerosis as a teen, May Ling Kopecky uses her art to share with others what it's like to live with a chronic disease.
Double inversion recovery (DIR) MRI sequences have been described in multiple adult multiple sclerosis studies to be sensitive for cortical lesions. These ...
Mayo Clinic researchers are working to improve the diagnosis and treatment of multiple sclerosis. Specific efforts include finding causes of the disease and ...
Multiple sclerosis, also called MS, is a disease in which the immune system attacks the covering surrounding the nerves in your brain and spinal cord. This ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.